Tag: Schizophrenia

AbbVie to acquire Cerevel Therapeutics for $8.7bn to expand neuroscience research

businessnewstoday- December 7, 2023

AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) have announced a definitive agreement in which AbbVie will acquire Cerevel Therapeutics. The transaction, valued at ... Read More

Teva Pharmaceuticals, MedinCell get UZEDY FDA approval for schizophrenia

businessnewstoday- April 30, 2023

Teva Pharmaceuticals and MedinCell have bagged approval for UZEDY (risperidone) extended-release injectable suspension from the US Food and Drug Administration (FDA) for schizophrenia treatment in ... Read More

Glenmark Pharmaceuticals gets FDA final approval for Compazine generic

businessnewstoday- March 20, 2023

Glenmark Pharmaceuticals has bagged final approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg from the US Food & Drug Administration (FDA). The ... Read More

Zydus Lifesciences gets FDA final approval for Olanzapine tablets

businessnewstoday- March 11, 2023

Zydus Lifesciences said that it has secured final approval for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10mg, 15 mg, and 20 mg from the ... Read More

Lupin launches schizophrenia drug Invega generic in US

businessnewstoday- October 21, 2022

Indian pharma company Lupin Limited has launched Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg in the US. The product is ... Read More

Zydus Lifesciences bags FDA approval for Cariprazine generic

pallavi123- September 17, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration ... Read More

Zydus Cadila gets FDA tentative approval for Cariprazine Capsules

pallavi123- December 12, 2021

Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval from the US Food and Drug Administration (FDA) to commercialize Cariprazine Capsules ... Read More

Unichem Laboratories gets FDA approval for Aripiprazole Tablets, USP

pallavi123- July 1, 2021

Unichem Laboratories said that it has secured a tentative approval for abbreviated new drug application (ANDA) of Aripiprazole Tablets, USP, 2mg, 5mg, 10mg, 15mg, 20mg, ... Read More

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets

pallavi123- May 29, 2021

Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine ... Read More

Novartis to acquire neuroscience company Cadent Therapeutics in $770m worth deal

pharmanewsdaily- December 19, 2020

Novartis acquisition of Cadent Therapeutics : Swiss pharma giant Novartis has agreed to acquire a US neuroscience company Cadent Therapeutics, in a deal worth up ... Read More